|
|
|
Volumn 26, Issue 2 SUPPL. 7, 1999, Pages 72-81
|
|
Amifostine reduces the incidence of cumulative nephrotoxicity from cisplatin: Laboratory and clinical aspects
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMIFOSTINE;
CISPLATIN;
ADULT;
AGED;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BLOOD TOXICITY;
CANCER STAGING;
CANCER SURVIVAL;
CREATININE BLOOD LEVEL;
DRUG EFFECT;
FEMALE;
HUMAN;
INCIDENCE;
MAJOR CLINICAL STUDY;
MEMBRANE BINDING;
NEPHROTOXICITY;
OVARY CANCER;
PRIORITY JOURNAL;
AMIFOSTINE;
ANIMALS;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CISPLATIN;
CLINICAL TRIALS;
CYCLOPHOSPHAMIDE;
CYTOPROTECTION;
DRUG EVALUATION, PRECLINICAL;
FEMALE;
HUMANS;
KIDNEY;
KIDNEY DISEASES;
MICE;
OVARIAN NEOPLASMS;
PROTECTIVE AGENTS;
RATS;
|
|
EID: 0032994889
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (56)
|
|
References (68)
|
